Overview

Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study will investigate how well adalimumab works in people with hidradenitis suppurativa (HS) in the short and long term.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott
Treatments:
Adalimumab